Advertisement

Topics

Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

11:14 EST 11 Jan 2019 | SCRIP

Denali will collaborate with Sirion in Parkinson’s and Alzheimer’s diseases. Meanwhile, Lundbeck and Elevian unveil drug development partnerships with technology...

      

Related Stories

 

Original Article: Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

NEXT ARTICLE

More From BioPortfolio on "Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...